NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Z

Zhongguancun Translational Medicine Technology (Chongqing) Co., Ltd.

Chongqing

Overview

Zhongguancun Translational Medicine Technology is a contract research organization (CRO) that also makes investments. The company focuses on the research and development of innovative drugs and provides translational medicine research services.

Year Founded

2018

Portfolio Companies

1

Investments

Zhongguancun Translational Medicine Technology (Chongqing) Co., Ltd. investments
CompanyDateStageLead
FlashDx Inc.Jan 2019AngelCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersChongqing
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.